AKR1C1 and non-small cell lung carcinoma: Our previous studies have demonstrated that aldo-keto reductase 1C1 (AKR1C1) promotes non-small cell lung cancer (NSCLC) metastasis by directly interacting with signal transducer and activator of transcription-3 (STAT3) and reinforcing its activity.2